SUPN· Supernus Pharmaceuticals Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 17 | $9M |
Quarterly ownership history
Last 5 quarters
SUPN Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$3.0B
Enterprise value$2.6B
EV / EBITDA (TTM)21.59
P/E ratio (TTM)—
Forward P/E13.09
P/S ratio3.85
P/B ratio2.79
PEG ratio—
Cash Flow
Operating cash flow (TTM)$83M
Free cash flow (TTM)$133M
Total cash$384M
Total debt$41M
Debt / equity3.80
Current ratio1.96
Income Statement
Total revenue (TTM)$777M
Revenue per share (TTM)13.65
Gross profit (TTM)$576M
EBITDA (TTM)$123M
Net income (TTM)-$29M
EPS diluted (TTM)-0.51
Shares outstanding58,039,721
Float shares52,247,357
Profitability
Gross margin74.13%
Operating margin-3.58%
EBITDA margin15.79%
Net margin-3.74%
Efficiency
Return on assets (TTM)1.11%
Return on equity (TTM)-2.75%
Price History
Current price$51.53
52 Week high$59.68
52 Week low$30.83
50 day average$50.82
200 day average$48.13
Average volume (10 day)974,260
1-year beta0.57
1-year price target$62.83
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:41 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com